BG98684A - 3-(n-isopropyl-n-h-propylamino)-5-(n-isopropyl) carbonoylchroman - Google Patents
3-(n-isopropyl-n-h-propylamino)-5-(n-isopropyl) carbonoylchromanInfo
- Publication number
- BG98684A BG98684A BG98684A BG9868494A BG98684A BG 98684 A BG98684 A BG 98684A BG 98684 A BG98684 A BG 98684A BG 9868494 A BG9868494 A BG 9868494A BG 98684 A BG98684 A BG 98684A
- Authority
- BG
- Bulgaria
- Prior art keywords
- isopropyl
- propylamino
- depression
- carbonoylchroman
- carbamoylchroma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9102905A SE9102905D0 (sv) | 1991-10-08 | 1991-10-08 | A new therapeutically active compound and a process for its preparation |
| SE9202000A SE9202000D0 (sv) | 1992-06-29 | 1992-06-29 | A new therapeutically active compound |
| PCT/SE1992/000708 WO1993007135A1 (en) | 1991-10-08 | 1992-10-08 | 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)carbamoylchroman |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG98684A true BG98684A (en) | 1995-05-31 |
Family
ID=26661197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG98684A BG98684A (en) | 1991-10-08 | 1994-03-29 | 3-(n-isopropyl-n-h-propylamino)-5-(n-isopropyl) carbonoylchroman |
Country Status (32)
| Country | Link |
|---|---|
| EP (3) | EP0703229A3 (is) |
| JP (1) | JPH07500320A (is) |
| CN (2) | CN1072411A (is) |
| AP (1) | AP338A (is) |
| AT (1) | ATE139774T1 (is) |
| AU (1) | AU667687B2 (is) |
| BG (1) | BG98684A (is) |
| CA (1) | CA2118708A1 (is) |
| CY (1) | CY1992A (is) |
| CZ (1) | CZ51094A3 (is) |
| DE (1) | DE69211857T2 (is) |
| DK (1) | DK0607274T3 (is) |
| EE (1) | EE02981B1 (is) |
| ES (1) | ES2089571T3 (is) |
| FI (1) | FI941616A (is) |
| GR (1) | GR3020608T3 (is) |
| HK (1) | HK55997A (is) |
| HR (1) | HRP920935A2 (is) |
| HU (1) | HUT68834A (is) |
| IL (1) | IL103373A0 (is) |
| IS (2) | IS1644B (is) |
| MA (1) | MA22674A1 (is) |
| MX (1) | MX9205744A (is) |
| MY (1) | MY131174A (is) |
| NO (1) | NO941256L (is) |
| NZ (2) | NZ270595A (is) |
| PL (1) | PL171013B1 (is) |
| SI (1) | SI9200249A (is) |
| SK (1) | SK36194A3 (is) |
| TN (1) | TNSN92088A1 (is) |
| WO (1) | WO1993007135A1 (is) |
| YU (1) | YU90492A (is) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420151A (en) * | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
| US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
| US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| CA2345079C (en) * | 1998-09-23 | 2011-06-21 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| US6235938B1 (en) * | 1999-06-10 | 2001-05-22 | Yale University | Transition metal-catalyzed process for preparing N-aryl amine compounds |
| KR20190065246A (ko) | 2016-07-29 | 2019-06-11 | 선오비온 파마슈티컬스 인코포레이티드 | 화합물 및 조성물 및 이들의 용도 |
| SG11202000669VA (en) | 2017-08-02 | 2020-02-27 | Sunovion Pharmaceuticals Inc | Isochroman compounds and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3679378D1 (de) * | 1985-09-03 | 1991-06-27 | Ciba Geigy Ag | 3-amino-dihydro-(1)-benzopyrane und benzothiopyrane. |
| US4801605A (en) * | 1986-08-29 | 1989-01-31 | Ciba-Geigy Corporation | 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans |
| SE8605504D0 (sv) * | 1986-12-19 | 1986-12-19 | Astra Laekemedel Ab | Novel chroman derivatives |
| JPH021429A (ja) * | 1988-06-09 | 1990-01-05 | Toray Ind Inc | 光学活性１−メチル−３−フェニルプロピルアミンの製造方法 |
| SE8904361D0 (sv) * | 1989-12-22 | 1989-12-22 | Astra Ab | New chroman and thiochroman derivatives |
-
1992
- 1992-10-02 HR HR920935A patent/HRP920935A2/hr not_active Application Discontinuation
- 1992-10-05 NZ NZ270595A patent/NZ270595A/en unknown
- 1992-10-05 MY MYPI92001795A patent/MY131174A/en unknown
- 1992-10-05 NZ NZ244618A patent/NZ244618A/en unknown
- 1992-10-07 MA MA22959A patent/MA22674A1/fr unknown
- 1992-10-07 IS IS3929A patent/IS1644B/is unknown
- 1992-10-07 MX MX9205744A patent/MX9205744A/es unknown
- 1992-10-08 AU AU27684/92A patent/AU667687B2/en not_active Ceased
- 1992-10-08 PL PL92303101A patent/PL171013B1/pl unknown
- 1992-10-08 AP APAP/P/1992/000434A patent/AP338A/en active
- 1992-10-08 SI SI19929200249A patent/SI9200249A/sl unknown
- 1992-10-08 SK SK361-94A patent/SK36194A3/sk unknown
- 1992-10-08 WO PCT/SE1992/000708 patent/WO1993007135A1/en not_active Application Discontinuation
- 1992-10-08 IL IL103373A patent/IL103373A0/xx unknown
- 1992-10-08 TN TNTNSN92088A patent/TNSN92088A1/fr unknown
- 1992-10-08 DK DK92921525.9T patent/DK0607274T3/da active
- 1992-10-08 EP EP95118114A patent/EP0703229A3/en not_active Withdrawn
- 1992-10-08 DE DE69211857T patent/DE69211857T2/de not_active Expired - Fee Related
- 1992-10-08 CN CN92112826A patent/CN1072411A/zh active Pending
- 1992-10-08 CA CA002118708A patent/CA2118708A1/en not_active Abandoned
- 1992-10-08 HU HU9400993A patent/HUT68834A/hu unknown
- 1992-10-08 YU YU90492A patent/YU90492A/sh unknown
- 1992-10-08 ES ES92921525T patent/ES2089571T3/es not_active Expired - Lifetime
- 1992-10-08 JP JP5506849A patent/JPH07500320A/ja active Pending
- 1992-10-08 CZ CZ94510A patent/CZ51094A3/cs unknown
- 1992-10-08 EP EP92850237A patent/EP0538222A1/en active Pending
- 1992-10-08 AT AT92921525T patent/ATE139774T1/de not_active IP Right Cessation
- 1992-10-08 EP EP92921525A patent/EP0607274B1/en not_active Expired - Lifetime
- 1992-12-08 IS IS4310A patent/IS4310A/is unknown
-
1994
- 1994-03-29 BG BG98684A patent/BG98684A/xx unknown
- 1994-04-07 NO NO941256A patent/NO941256L/no unknown
- 1994-04-08 FI FI941616A patent/FI941616A/fi not_active Application Discontinuation
- 1994-11-23 EE EE9400368A patent/EE02981B1/xx unknown
-
1996
- 1996-02-28 CN CN96103466A patent/CN1146992A/zh active Pending
- 1996-07-23 GR GR960401967T patent/GR3020608T3/el unknown
-
1997
- 1997-05-01 HK HK55997A patent/HK55997A/xx not_active IP Right Cessation
- 1997-09-05 CY CY199297A patent/CY1992A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW229205B (is) | ||
| DE60222698D1 (de) | Heteroarylsubstituierte triazolmodulatoren des metabotropen glutamatarezeptors 5 | |
| RU2008123376A (ru) | Производные 4-(4-алкокси-3-гидроксифенил)-2-пирролидона в качестве ингибиторов pde-4 для лечения неврологических синдромов | |
| NO20013546L (no) | Godt renset etyl-EPA og andre EPA-derivater for psykiatriske og nevrologiske sykdommer | |
| DK0604494T3 (da) | 5-HT4-receptorantagonister | |
| GR3031492T3 (en) | 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders | |
| FI941829A0 (fi) | (S)-4-(4-dimetyyliamino)-1-(4'-fluorifenyyli)-1-(hydroksibutyyli)bentsonitriilijohdannainen | |
| BG98684A (en) | 3-(n-isopropyl-n-h-propylamino)-5-(n-isopropyl) carbonoylchroman | |
| DK0474580T3 (da) | Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme | |
| RU94046141A (ru) | Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция | |
| KR970001306A (ko) | 향멜라토닌성 n-아실-2-아릴 시클로알킬메틸아민 유도체 및 이를 함유한 약제조성물 | |
| FI92320C (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi | |
| ATE152708T1 (de) | (1,2n) und (3,2n)-karbozyklische-2-amino- tetralinderivate | |
| KR920701122A (ko) | 신규 이환식 아미노-치환 화합물 | |
| DK0548664T3 (da) | 2,3,3a,4,5,9b-Hexahydro- 1H-benzo (e)indol-derivater | |
| MX9205365A (es) | Imidazolilmetil-piridinas y composicion farmaceutica que las contiene. | |
| KR880007495A (ko) | 5-아릴-3h-1,2,4-트리아졸-3-온 및 신경변성 질환의 치료에 있어서의 그들의 용도 | |
| IL160615A0 (en) | Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders | |
| RU94021108A (ru) | 3-/n-изопропил -n-n-пропиламино/-5-/n-изопропил/ -карбамоилхроман, способ его получения, фармацевтическая композиция, способ лечения, способ получения /r/ -3-амино-5-метоксихромана | |
| PT1140830E (pt) | Derivados de arilpiperidina e aril-1,2,5,6-tetra-hidro-piridina amida possuindo actividade receptora de 5ht1a | |
| DK249288D0 (da) | Substituerede silylalkylenaminer og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse | |
| DE69233124D1 (de) | Verwendung von reinem fluoxetin-s(+)-isomer für die herstellung eines medikements gegen migräne | |
| ATE240959T1 (de) | Chromeno(4,3,2-de)isochinoline als wirksame dopaminrezeptor-liganden | |
| ATE283269T1 (de) | 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems | |
| ZA9210120B (en) | N-(3-(2-(1 H-imidazol-1-yl)ethoxy)-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts |